NEW YORK (AdAge.com) -- Pharmaceutical giant GlaxoSmithKline has moved the professional advertising accounts for six brands to Interpublic Group of Cos.' FCB Healthcare and Torre Lazur McCann. WPP Group's Grey Healthcare will lose the Advair account, valued at $100 million, as part of the consolidation.
According to a report in Medical Marketing & Media, the decision was made after a review involving both holding companies; the transfer will be complete by the end of the year.
A spokesman within WPP said Grey Healthcare will lose Advair and Seretide (both asthma medications), as well as Imitrex (migraine treatment). Fellow WPP agency CommonHealth's Ferguson will lose Avodart (for benign prostatic hyperplasia), Avandia and Avandament (both for diabetes).
Grey Worldwide will continue to handle consumer advertising for several GSK brands.